Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reaffirms Positive Outlook on Airgain with Price Target Increase Chief Revenue Officer Resigns

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Technology Artificial intelligence Market Capitalization
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

On March 7, 2024, Northland Capital Markets analyst Gus Richard reaffirmed his positive outlook on Airgain (NASDAQ:AIRG) with an Outperform rating. He raised the price target for the stock from $4 to $6.

In other news, Airgain, Inc. disclosed that Morad Sbahi will be stepping down from his role as Chief Revenue Officer, with his resignation becoming effective on June 12.

Airgain Inc. (AIRG) Shows Strong Performance in Stock Market: March 7, 2024 Analysis

On March 7, 2024, Airgain Inc. (AIRG) showed strong performance in the stock market. The stock closed at $5.01, marking a significant increase of $0.38 or 8.21% since the previous market close. Additionally, in after-hours trading, the stock continued to rise, gaining an additional $0.08.

Looking at the overall trend, AIRG is currently trading in the middle of its 52-week range, indicating stability in its price movement. Moreover, the stock is trading above its 200-day simple moving average, which is a positive sign for investors as it suggests a bullish trend.

The price momentum of AIRG on March 7, 2024, reflects investor confidence in the company’s performance and potential growth prospects. The significant increase in the stock price indicates that investors are optimistic about the company’s future earnings and overall market position.

Overall, the strong performance of AIRG on March 7, 2024, highlights the company’s potential for growth and profitability in the future. Investors will be closely monitoring the stock’s performance in the coming days to assess any further developments.

AIRG Stock Performance Analysis: Revenue and Net Income Decline in Past Year with Slight Improvement in Fourth Quarter

On March 7, 2024, AIRG stock saw some mixed performances based on the financial data provided by CNN Money. The total revenue for the company stood at $56.04 million for the past year, with a decrease of 26.16% compared to the previous year. In the fourth quarter, the total revenue was $10.07 million, which remained flat compared to the previous quarter.

The net income for AIRG was reported at -$12.43 million for the past year, showing a decrease of 43.53% compared to the previous year. In the fourth quarter, the net income improved slightly to -$5.48 million, with a 0.0% increase compared to the previous quarter.

Earnings per share (EPS) for AIRG were reported at -$1.20 for the past year, reflecting a decrease of 40.73% compared to the previous year. In the fourth quarter, the EPS improved to -$0.52, with a 0.0% increase compared to the previous quarter.

Tags: AIRG
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Rush Street Interactive Inc NYSE RSI Reports Strong Fourth Quarter Results and Optimistic Revenue Forecast for 2024

Technology Robotics Markets and money

Brian Belski Trims Stake in Nvidia A Strategic Investment Decision

Music Industry Stock Market Today

Believe SA Receives Merger Offer from Warner Music at 17 Per Share

Recommended

Biotechnology Stock Exchange

Analysts Bullish on Dynatrace with Price Targets on the Rise

2 years ago
The Trade Desk Stock

The Trade Desk Faces Mounting Pressure as Amazon Strikes Netflix Deal

5 months ago

Analyst Reaffirms Buy Rating on International Seaways with 66 Price Target

2 years ago
Biotechnology Stock Bull Market

KeyBanc Analyst Raises Price Target and Maintains Overweight Rating on Repligen NASDAQ RGEN

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Trending

Puma Biotechnology Stock
Earnings

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

by Jackson Burston
February 8, 2026
0

Investor attention is now firmly fixed on February 26, 2026, as Puma Biotechnology prepares to release its...

Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test
  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com